In this project, an alternative approach for the detection of ADR signals will be developed. Rather than relying on the physician's capability and willingness to recognize and report suspected ADRs, the system will systematically calculate the occurrence of disease (potentially ADRs) during specific drug use based on data available in electronic patient records. In this project, electronic health records (EHRs) of over 30 million patients from several European countries will be available. In an environment where rapid signal detection is feasible, rapid signal assessment is equally important. To rapidly assess signals, a number of resources will be used to substantiate the signals: causal reasoning based on information in the EHRs, semantic mining of the biomedical literature, and computational analysis of biological and chemical information (drugs, targets, anti-targets, SNPs, pathways, etc.).
The overall objective of this project is the design, development and validation of a computerized system that exploits data from electronic healthcare records and biomedical databases for the early detection of adverse drug reactions. The ALERT system will generate signals using data and text mining, epidemiological and other computational techniques, and subsequently substantiate these signals in the light of current knowledge of biological mechanisms and in silico prediction capabilities. The system should be able to detect signals better and faster than spontaneous reporting systems and should allow for identification of subpopulations at higher risk for ADRs.
For further information, please visit:
- Erasmus University Medical Centre Rotterdam
- IMIM Foundation (Fundació Institut Municipal d'Investigació Mèdica), Barcelona
Project co-ordinator:
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
Partners:
- SOCIETA SERVIZI TELEMATICI SRL
- UNIVERSIDADE DE AVEIRO
- THE UNIVERSITY OF NOTTINGHAM
- PHARMO COOPERATIE UA
- AARHUS UNIVERSITETSHOSPITAL, AARHUS SYGEHUS
- UNIVERSIDADE DE SANTIAGO DE COMPOSTELA
- UNIVERSITAT POMPEU FABRA
- IRCCS CENTRO NEUROLESI BONINO PULEJO
- FUNDACIO IMIM
- LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE
- ASTRAZENECA AB
- UNIVERSITE VICTOR SEGALEN BORDEAUX II
- AGENZIA REGIONALE DI SANITA
- UNIVERSITA DEGLI STUDI DI MILANO - BICOCCA
Timetable: from 02/2008 to 07/2011
Total cost: 5.880.600
EC funding: 4.500.000
Programme Acronym: FP7-ICT
Subprogramme Area: Advanced ICT for risk assessment and patient safety
Contract type: Collaborative project (generic)
Related news article: